Global Locations

Favipiravir



Chemical Properties of 'Favipiravir'

CAT No. :

CS-O-13215
CAS Registry No. : 259793-96-9
Category : API Standards
Molecular Weight: 157.10
Molecular Formula : C₅H₄FN₃O₂



OTHER INFORMATION of 'Favipiravir'
Therapeutic : COVID19
Therapeutic : COVID19
IUPAC Name :5-fluoro-2-oxo-1H-pyrazine-3-carboxamide
Synonym :Not available
Smileys :NC(C1=NC(F)=CNC1=O)=O
Melting Point :187℃ to 193℃
Solubility :slightly soluble in water
Hazard Class :Acute Tox. 4 (66.67%)
EC Number :856-840-0
UNII :EW5GL2X7E0
NCI Thesaurus Code :C81605
MeSH Entry Terms :6-fluoro-3-hydroxy-2-pyrazinecarboxamide
Other Synonyms :Favipiravir
Removed Synonyms :Favipiravir [INN]
Toxicity Summary :Based on single-dose toxicity studies, the lethal dose for oral and intravenous favipiravir in mice is estimated to be >2000 mg/kg. In rats, the lethal dose for oral administration is >2000 mg/kg, while the lethal dose in dogs and monkeys is >1000 mg/kg. Symptoms of overdose appear to include but are not limited to reduced body weight, vomiting, and decreased locomotor activity. In repeat-dose toxicity studies involving dogs, rats, and monkeys, notable findings after administration of oral favipiravir included: adverse effects on hematopoietic tissues such as decreased red blood cell (RBC) production, and increases in liver function parameters such as aspartate aminotransferase (AST), alkaline phosphatase (ALP), alanine aminotransferase (ALT) and total bilirubin, and increased vacuolization in hepatocytes. Testis toxicity was also noted. Favipiravir is known to be teratogenic; therefore, administration of favipiravir should be avoided in women if pregnancy is confirmed or suspected. Toxicity information regarding favipiravir in humans is not readily available.
Protein Binding :Favipiravir is 54% plasma protein-bound. Of this fraction, 65% is bound to serum albumin and 6.5% is bound to ɑ1-acid glycoprotein.
Exact Mass :157.02875454
InChI :InChI=1S/C5H4FN3O2/c6-2-1-8-5(11)3(9-2)4(7)10/h1H,(H2,7,10)(H,8,11)
InchIKey :ZCGNOVWYSGBHAU-UHFFFAOYSA-N
Canonical SMILES :C1=C(N=C(C(=O)N1)C(=O)N)F
Isomeric SMILES :C1=C(N=C(C(=O)N1)C(=O)N)F
Product Description :Favipiravir is a member of the class of pyrazines that is pyrazine substituted by aminocarbonyl, hydroxy and fluoro groups at positions 2, 3 and 6, respectively. It is an anti-viral agent that inhibits RNA-dependent RNA polymerase of several RNA viruses and is approved for the treatment of influenza in Japan. It has a role as an antiviral drug, an anticoronaviral agent and an EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor. It is a primary carboxamide, a hydroxypyrazine and an organofluorine compound.
Custom Duty : Applicable
Port of Loading : Canada
Expected Dispatch : 2-3 Weeks
Taxes : Not Applicable
Refund Policy : 30-days money back
Custom Duty : Applicable
Port of Loading : Canada
Expected Dispatch : 2-3 Weeks
Taxes : Not Applicable
Refund Policy : 30-days money back


Looking for a discounted price or need more info for 'Favipiravir (CS-O-13215)' ?

If you are looking for Bulk purchase, Discounted Price, etc. please share your email and the exact quantity you are looking for, our team will respond to you within 30 mins with all the required information.

Looking for a discounted price or need more info for 'Favipiravir (CS-O-13215)' ?

If you are looking for Bulk purchase, Discounted Price, etc. please share your email and the exact quantity you are looking for, our team will respond to you within 30 mins with all the required information.